Sensory, affective and evaluative features in patients with chronic migraine and chronic tension-type headache

October 11, 2024
379
УДК:  616.857
Specialities :
Resume

Migraine and tension headache are the most common types of headaches in all age categories all over the world. Because of its high prevalence, these pathologies have the greatest social and economic impact over other primary headaches. Thorough collection of complaints and anamnesis of the patient with headache, as well as the use of questionnaires and pain scales, still remain key methods for diagnosing primary headaches. The bright clinical characteristics of the pain syndrome are diminished because of chronic headache, which complicates diagnosis and reduces patient treatment effectiveness. The majority of the population is affected by chronic pain, which is a significant personal and socio-economic burden. Chronic constant pain with the component of affective arousal can have an impact on a patient’s quality of life, daily activities, psychological state, and overall well-being. The use of scales and questionnaires allows you to measure the intensity and other features of pain. The McGill Pain Questionnaire (MPQ) is a complex multidimensional tool that covers both neurophysiological and psychological aspects of pain. MPQ examines not only the intensity of pain, but also the quality of pain (sensory, affective, evaluative, and quantitative pain parameters). MPQ can provide more clinical information about pain in patients with chronic headache. In the present study, we compared the effectiveness of using the MPQ questionnaire in patients with chronic migraine and chronic tension-type headache. It was determined that the use of this questionnaire is a useful auxiliary method of differential diagnosis of chronic primary headaches.

References

  • 1. Ashina S., Bendtsen L., Burstein R. et al. (2022) Pain sensitivity in relation to frequency of migraine and tension-type headache with or without coexistent neck pain: an exploratory secondary analysis of the population study. Scand. J. Pain, 23(1): 76–87. doi: 10.1515/sjpain-2022-0030.
  • 2. Букреєва Ю.В., Кальбус О.І. (2024) Хронічний головний біль. Хронічна мігрень з щоденним головним болем (огляд літератури). Укр. мед. часопис, 4(162): umj.com.ua/uk/publikatsia-252564-hronichnij-golovnij-bil-hronichna-migren-z-shhodennim-golovnim-bolem-oglyad-literaturi.
  • 3. Gaul C., Meßlinger K., Holle-Lee D., Neeb L. (2017) Pathophysiology of Headaches. Dtsch Med Wochenschr., 142(6): 402–408. doi: 10.1055/s-0042-111694.
  • 4. Guven Kose S., Kose H.C., Celikel F. et al. (2022) Chronic Pain: An Update of Clinical Practices and Advances in Chronic Pain Management. Eurasian J. Med., 54(Suppl. 1): 57–61. doi: 10.5152/eurasianjmed.2022.22307.
  • 5. Melzack R. (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain, 1(3): 277–299. doi: 10.1016/0304-3959(75)90044-5.
  • 6. Vahedi M., Mazdeh M., Hajilooi M. et al. (2018) The Relationship Between Salivary Alpha Amylase Activity and Score of McGill Pain Questionnaire in Patients With Tension Type Headache. Basic Clin. Neurosci., 9(1): 59–64. doi: 10.29252/nirp.bcn.9.1.59.
  • 7. Mongini F., Deregibus A., Raviola F., Mongini T. (2003) Confirmation of the distinction between chronic migraine and chronic tension-type headache by the McGill Pain Questionnaire. Headache, 43(8): 867–877. doi.org/10.1 046/j.1526-4610.2003.03165.x.
  • 8. Elizagaray-García I., Carvalho G.F., Szikszay T.M. et al. (2022) Psychophysical testing in chronic migraine and chronic tension type headache: An observational study. Cephalalgia, 42(7): 618–630. doi: 10.1177/03331024211060315.
  • 9. Auvray M., Myin E., Spence C. (2010) The sensory-discriminative and affective-motivational aspects of pain. Neurosci. Biobehav. Rev., 34(2): 214–223. doi: 10.1016/j.neubiorev.2008.07.008.
  • 10. Kaniecki R.G., Friedman D.I., Asher D. et al. (2023) Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine. Pain Ther., 12(5): 1179–1194. doi: 10.1007/s40122-023-00525-x.
  • 11. Altamura C., Brunelli N., Viticchi G. et al. (2023) Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study. Toxins (Basel), 15(4): 284. doi: 10.3390/toxins15040284.